Stockysis — AI-Powered Stock News & Sentiment Analysis

Oppenheimer Maintains Outperform on Gossamer Bio, Lowers Price Target to $3

Benzinga Newsdesk www.benzinga.com Negative 82.5%

Neg 82.5% Neu 0% Pos 0%

Oppenheimer analyst Andreas Argyrides maintains Gossamer Bio (NASDAQ:GOSS) with a Outperform and lowers the price target from $12 to $3.

Comments

No comments yet. Be the first!